カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のプロゲステロン受容体アゴニスト市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Progesterone Receptor Agonist Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19571）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19571
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：93
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のプロゲステロン受容体アゴニスト市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

プロゲステロン受容体アゴニスト市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のプロゲステロン受容体アゴニストの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

プロゲステロン受容体アゴニスト市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・天然プロゲステロン受容体作動薬、合成プロゲステロン受容体作動薬

用途別セグメントは次のように区分されます。
・避妊、機能不全子宮出血、子宮内膜がん、増殖性前駆病変、月経周期調節、その他

世界のプロゲステロン受容体アゴニスト市場の主要な市場プレーヤーは以下のとおりです。
・TherapeuticsMD、Evestra、Anavex Life Sciences、Encore Therapeutics、Lipocine、Orion、Exeltis、Estetra S.A.、Bayer Schering Pharma

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、プロゲステロン受容体アゴニスト製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なプロゲステロン受容体アゴニストメーカーの企業概要、2019年～2022年までのプロゲステロン受容体アゴニストの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なプロゲステロン受容体アゴニストメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別プロゲステロン受容体アゴニストの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのプロゲステロン受容体アゴニストの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのプロゲステロン受容体アゴニスト市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびプロゲステロン受容体アゴニストの産業チェーンを掲載しています。
・第13、14、15章では、プロゲステロン受容体アゴニストの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- プロゲステロン受容体アゴニストの概要
- 種類別分析（2017年vs2021年vs2028年）：天然プロゲステロン受容体作動薬、合成プロゲステロン受容体作動薬
- 用途別分析（2017年vs2021年vs2028年）：避妊、機能不全子宮出血、子宮内膜がん、増殖性前駆病変、月経周期調節、その他
- 世界のプロゲステロン受容体アゴニスト市場規模・予測
- 世界のプロゲステロン受容体アゴニスト生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- TherapeuticsMD、Evestra、Anavex Life Sciences、Encore Therapeutics、Lipocine、Orion、Exeltis、Estetra S.A.、Bayer Schering Pharma
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：天然プロゲステロン受容体作動薬、合成プロゲステロン受容体作動薬
・用途別分析2017年-2028年：避妊、機能不全子宮出血、子宮内膜がん、増殖性前駆病変、月経周期調節、その他
・プロゲステロン受容体アゴニストの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・プロゲステロン受容体アゴニストのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・プロゲステロン受容体アゴニストのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・プロゲステロン受容体アゴニストの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・プロゲステロン受容体アゴニストの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Progesterone Receptor Agonist market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Progesterone Receptor Agonist market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Contraception accounting for % of the Progesterone Receptor Agonist global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Natural Progesterone Receptor Agonist segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Progesterone Receptor Agonist include TherapeuticsMD, Evestra, Anavex Life Sciences, Encore Therapeutics, and Lipocine, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Progesterone Receptor Agonist market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Natural Progesterone Receptor Agonist
Synthetic Progesterone Receptor Agonist
Market segment by Application can be divided into
Contraception
Dysfunctional Uterine Bleeding
Endometrial Cancer
Proliferative Precursor Lesions
Menstrual Cycle Regulation
Others
The key market players for global Progesterone Receptor Agonist market are listed below:
TherapeuticsMD
Evestra
Anavex Life Sciences
Encore Therapeutics
Lipocine
Orion
Exeltis
Estetra S.A.
Bayer Schering Pharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Progesterone Receptor Agonist product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Progesterone Receptor Agonist, with price, sales, revenue and global market share of Progesterone Receptor Agonist from 2019 to 2022.
Chapter 3, the Progesterone Receptor Agonist competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Progesterone Receptor Agonist breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Progesterone Receptor Agonist market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Progesterone Receptor Agonist.
Chapter 13, 14, and 15, to describe Progesterone Receptor Agonist sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Progesterone Receptor Agonist Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Progesterone Receptor Agonist Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Natural Progesterone Receptor Agonist
1.2.3 Synthetic Progesterone Receptor Agonist
1.3 Market Analysis by Application
1.3.1 Overview: Global Progesterone Receptor Agonist Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Contraception
1.3.3 Dysfunctional Uterine Bleeding
1.3.4 Endometrial Cancer
1.3.5 Proliferative Precursor Lesions
1.3.6 Menstrual Cycle Regulation
1.3.7 Others
1.4 Global Progesterone Receptor Agonist Market Size & Forecast
1.4.1 Global Progesterone Receptor Agonist Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Progesterone Receptor Agonist Sales in Volume (2017-2028)
1.4.3 Global Progesterone Receptor Agonist Price (2017-2028)
1.5 Global Progesterone Receptor Agonist Production Capacity Analysis
1.5.1 Global Progesterone Receptor Agonist Total Production Capacity (2017-2028)
1.5.2 Global Progesterone Receptor Agonist Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Progesterone Receptor Agonist Market Drivers
1.6.2 Progesterone Receptor Agonist Market Restraints
1.6.3 Progesterone Receptor Agonist Trends Analysis
2 Manufacturers Profiles
2.1 TherapeuticsMD
2.1.1 TherapeuticsMD Details
2.1.2 TherapeuticsMD Major Business
2.1.3 TherapeuticsMD Progesterone Receptor Agonist Product and Services
2.1.4 TherapeuticsMD Progesterone Receptor Agonist Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Evestra
2.2.1 Evestra Details
2.2.2 Evestra Major Business
2.2.3 Evestra Progesterone Receptor Agonist Product and Services
2.2.4 Evestra Progesterone Receptor Agonist Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Anavex Life Sciences
2.3.1 Anavex Life Sciences Details
2.3.2 Anavex Life Sciences Major Business
2.3.3 Anavex Life Sciences Progesterone Receptor Agonist Product and Services
2.3.4 Anavex Life Sciences Progesterone Receptor Agonist Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Encore Therapeutics
2.4.1 Encore Therapeutics Details
2.4.2 Encore Therapeutics Major Business
2.4.3 Encore Therapeutics Progesterone Receptor Agonist Product and Services
2.4.4 Encore Therapeutics Progesterone Receptor Agonist Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Lipocine
2.5.1 Lipocine Details
2.5.2 Lipocine Major Business
2.5.3 Lipocine Progesterone Receptor Agonist Product and Services
2.5.4 Lipocine Progesterone Receptor Agonist Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Orion
2.6.1 Orion Details
2.6.2 Orion Major Business
2.6.3 Orion Progesterone Receptor Agonist Product and Services
2.6.4 Orion Progesterone Receptor Agonist Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Exeltis
2.7.1 Exeltis Details
2.7.2 Exeltis Major Business
2.7.3 Exeltis Progesterone Receptor Agonist Product and Services
2.7.4 Exeltis Progesterone Receptor Agonist Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Estetra S.A.
2.8.1 Estetra S.A. Details
2.8.2 Estetra S.A. Major Business
2.8.3 Estetra S.A. Progesterone Receptor Agonist Product and Services
2.8.4 Estetra S.A. Progesterone Receptor Agonist Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Bayer Schering Pharma
2.9.1 Bayer Schering Pharma Details
2.9.2 Bayer Schering Pharma Major Business
2.9.3 Bayer Schering Pharma Progesterone Receptor Agonist Product and Services
2.9.4 Bayer Schering Pharma Progesterone Receptor Agonist Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Progesterone Receptor Agonist Breakdown Data by Manufacturer
3.1 Global Progesterone Receptor Agonist Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Progesterone Receptor Agonist Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Progesterone Receptor Agonist
3.4 Market Concentration Rate
3.4.1 Top 3 Progesterone Receptor Agonist Manufacturer Market Share in 2021
3.4.2 Top 6 Progesterone Receptor Agonist Manufacturer Market Share in 2021
3.5 Global Progesterone Receptor Agonist Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Progesterone Receptor Agonist Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Progesterone Receptor Agonist Market Size by Region
4.1.1 Global Progesterone Receptor Agonist Sales in Volume by Region (2017-2028)
4.1.2 Global Progesterone Receptor Agonist Revenue by Region (2017-2028)
4.2 North America Progesterone Receptor Agonist Revenue (2017-2028)
4.3 Europe Progesterone Receptor Agonist Revenue (2017-2028)
4.4 Asia-Pacific Progesterone Receptor Agonist Revenue (2017-2028)
4.5 South America Progesterone Receptor Agonist Revenue (2017-2028)
4.6 Middle East and Africa Progesterone Receptor Agonist Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Progesterone Receptor Agonist Sales in Volume by Type (2017-2028)
5.2 Global Progesterone Receptor Agonist Revenue by Type (2017-2028)
5.3 Global Progesterone Receptor Agonist Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Progesterone Receptor Agonist Sales in Volume by Application (2017-2028)
6.2 Global Progesterone Receptor Agonist Revenue by Application (2017-2028)
6.3 Global Progesterone Receptor Agonist Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Progesterone Receptor Agonist Sales by Type (2017-2028)
7.2 North America Progesterone Receptor Agonist Sales by Application (2017-2028)
7.3 North America Progesterone Receptor Agonist Market Size by Country
7.3.1 North America Progesterone Receptor Agonist Sales in Volume by Country (2017-2028)
7.3.2 North America Progesterone Receptor Agonist Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Progesterone Receptor Agonist Sales by Type (2017-2028)
8.2 Europe Progesterone Receptor Agonist Sales by Application (2017-2028)
8.3 Europe Progesterone Receptor Agonist Market Size by Country
8.3.1 Europe Progesterone Receptor Agonist Sales in Volume by Country (2017-2028)
8.3.2 Europe Progesterone Receptor Agonist Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Progesterone Receptor Agonist Sales by Type (2017-2028)
9.2 Asia-Pacific Progesterone Receptor Agonist Sales by Application (2017-2028)
9.3 Asia-Pacific Progesterone Receptor Agonist Market Size by Region
9.3.1 Asia-Pacific Progesterone Receptor Agonist Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Progesterone Receptor Agonist Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Progesterone Receptor Agonist Sales by Type (2017-2028)
10.2 South America Progesterone Receptor Agonist Sales by Application (2017-2028)
10.3 South America Progesterone Receptor Agonist Market Size by Country
10.3.1 South America Progesterone Receptor Agonist Sales in Volume by Country (2017-2028)
10.3.2 South America Progesterone Receptor Agonist Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Progesterone Receptor Agonist Sales by Type (2017-2028)
11.2 Middle East & Africa Progesterone Receptor Agonist Sales by Application (2017-2028)
11.3 Middle East & Africa Progesterone Receptor Agonist Market Size by Country
11.3.1 Middle East & Africa Progesterone Receptor Agonist Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Progesterone Receptor Agonist Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Progesterone Receptor Agonist and Key Manufacturers
12.2 Manufacturing Costs Percentage of Progesterone Receptor Agonist
12.3 Progesterone Receptor Agonist Production Process
12.4 Progesterone Receptor Agonist Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Progesterone Receptor Agonist Typical Distributors
13.3 Progesterone Receptor Agonist Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Progesterone Receptor Agonist Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Progesterone Receptor Agonist Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. TherapeuticsMD Basic Information, Manufacturing Base and Competitors
Table 4. TherapeuticsMD Major Business
Table 5. TherapeuticsMD Progesterone Receptor Agonist Product and Services
Table 6. TherapeuticsMD Progesterone Receptor Agonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Evestra Basic Information, Manufacturing Base and Competitors
Table 8. Evestra Major Business
Table 9. Evestra Progesterone Receptor Agonist Product and Services
Table 10. Evestra Progesterone Receptor Agonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Anavex Life Sciences Basic Information, Manufacturing Base and Competitors
Table 12. Anavex Life Sciences Major Business
Table 13. Anavex Life Sciences Progesterone Receptor Agonist Product and Services
Table 14. Anavex Life Sciences Progesterone Receptor Agonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Encore Therapeutics Basic Information, Manufacturing Base and Competitors
Table 16. Encore Therapeutics Major Business
Table 17. Encore Therapeutics Progesterone Receptor Agonist Product and Services
Table 18. Encore Therapeutics Progesterone Receptor Agonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Lipocine Basic Information, Manufacturing Base and Competitors
Table 20. Lipocine Major Business
Table 21. Lipocine Progesterone Receptor Agonist Product and Services
Table 22. Lipocine Progesterone Receptor Agonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Orion Basic Information, Manufacturing Base and Competitors
Table 24. Orion Major Business
Table 25. Orion Progesterone Receptor Agonist Product and Services
Table 26. Orion Progesterone Receptor Agonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Exeltis Basic Information, Manufacturing Base and Competitors
Table 28. Exeltis Major Business
Table 29. Exeltis Progesterone Receptor Agonist Product and Services
Table 30. Exeltis Progesterone Receptor Agonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Estetra S.A. Basic Information, Manufacturing Base and Competitors
Table 32. Estetra S.A. Major Business
Table 33. Estetra S.A. Progesterone Receptor Agonist Product and Services
Table 34. Estetra S.A. Progesterone Receptor Agonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Bayer Schering Pharma Basic Information, Manufacturing Base and Competitors
Table 36. Bayer Schering Pharma Major Business
Table 37. Bayer Schering Pharma Progesterone Receptor Agonist Product and Services
Table 38. Bayer Schering Pharma Progesterone Receptor Agonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Progesterone Receptor Agonist Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Progesterone Receptor Agonist Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Progesterone Receptor Agonist, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Progesterone Receptor Agonist Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Progesterone Receptor Agonist Production Site of Key Manufacturer
Table 44. Progesterone Receptor Agonist New Entrant and Capacity Expansion Plans
Table 45. Progesterone Receptor Agonist Mergers & Acquisitions in the Past Five Years
Table 46. Global Progesterone Receptor Agonist Sales by Region (2017-2022) & (K Units)
Table 47. Global Progesterone Receptor Agonist Sales by Region (2023-2028) & (K Units)
Table 48. Global Progesterone Receptor Agonist Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Progesterone Receptor Agonist Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Progesterone Receptor Agonist Sales by Type (2017-2022) & (K Units)
Table 51. Global Progesterone Receptor Agonist Sales by Type (2023-2028) & (K Units)
Table 52. Global Progesterone Receptor Agonist Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Progesterone Receptor Agonist Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Progesterone Receptor Agonist Price by Type (2017-2022) & (US$/Unit)
Table 55. Global Progesterone Receptor Agonist Price by Type (2023-2028) & (US$/Unit)
Table 56. Global Progesterone Receptor Agonist Sales by Application (2017-2022) & (K Units)
Table 57. Global Progesterone Receptor Agonist Sales by Application (2023-2028) & (K Units)
Table 58. Global Progesterone Receptor Agonist Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Progesterone Receptor Agonist Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Progesterone Receptor Agonist Price by Application (2017-2022) & (US$/Unit)
Table 61. Global Progesterone Receptor Agonist Price by Application (2023-2028) & (US$/Unit)
Table 62. North America Progesterone Receptor Agonist Sales by Country (2017-2022) & (K Units)
Table 63. North America Progesterone Receptor Agonist Sales by Country (2023-2028) & (K Units)
Table 64. North America Progesterone Receptor Agonist Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Progesterone Receptor Agonist Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Progesterone Receptor Agonist Sales by Type (2017-2022) & (K Units)
Table 67. North America Progesterone Receptor Agonist Sales by Type (2023-2028) & (K Units)
Table 68. North America Progesterone Receptor Agonist Sales by Application (2017-2022) & (K Units)
Table 69. North America Progesterone Receptor Agonist Sales by Application (2023-2028) & (K Units)
Table 70. Europe Progesterone Receptor Agonist Sales by Country (2017-2022) & (K Units)
Table 71. Europe Progesterone Receptor Agonist Sales by Country (2023-2028) & (K Units)
Table 72. Europe Progesterone Receptor Agonist Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Progesterone Receptor Agonist Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Progesterone Receptor Agonist Sales by Type (2017-2022) & (K Units)
Table 75. Europe Progesterone Receptor Agonist Sales by Type (2023-2028) & (K Units)
Table 76. Europe Progesterone Receptor Agonist Sales by Application (2017-2022) & (K Units)
Table 77. Europe Progesterone Receptor Agonist Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Progesterone Receptor Agonist Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Progesterone Receptor Agonist Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Progesterone Receptor Agonist Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Progesterone Receptor Agonist Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Progesterone Receptor Agonist Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Progesterone Receptor Agonist Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Progesterone Receptor Agonist Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Progesterone Receptor Agonist Sales by Application (2023-2028) & (K Units)
Table 86. South America Progesterone Receptor Agonist Sales by Country (2017-2022) & (K Units)
Table 87. South America Progesterone Receptor Agonist Sales by Country (2023-2028) & (K Units)
Table 88. South America Progesterone Receptor Agonist Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Progesterone Receptor Agonist Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Progesterone Receptor Agonist Sales by Type (2017-2022) & (K Units)
Table 91. South America Progesterone Receptor Agonist Sales by Type (2023-2028) & (K Units)
Table 92. South America Progesterone Receptor Agonist Sales by Application (2017-2022) & (K Units)
Table 93. South America Progesterone Receptor Agonist Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Progesterone Receptor Agonist Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Progesterone Receptor Agonist Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Progesterone Receptor Agonist Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Progesterone Receptor Agonist Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Progesterone Receptor Agonist Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Progesterone Receptor Agonist Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Progesterone Receptor Agonist Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Progesterone Receptor Agonist Sales by Application (2023-2028) & (K Units)
Table 102. Progesterone Receptor Agonist Raw Material
Table 103. Key Manufacturers of Progesterone Receptor Agonist Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Progesterone Receptor Agonist Typical Distributors
Table 107. Progesterone Receptor Agonist Typical Customers
List of Figures
Figure 1. Progesterone Receptor Agonist Picture
Figure 2. Global Progesterone Receptor Agonist Revenue Market Share by Type in 2021
Figure 3. Natural Progesterone Receptor Agonist
Figure 4. Synthetic Progesterone Receptor Agonist
Figure 5. Global Progesterone Receptor Agonist Revenue Market Share by Application in 2021
Figure 6. Contraception
Figure 7. Dysfunctional Uterine Bleeding
Figure 8. Endometrial Cancer
Figure 9. Proliferative Precursor Lesions
Figure 10. Menstrual Cycle Regulation
Figure 11. Others
Figure 12. Global Progesterone Receptor Agonist Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 13. Global Progesterone Receptor Agonist Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Progesterone Receptor Agonist Sales (2017-2028) & (K Units)
Figure 15. Global Progesterone Receptor Agonist Price (2017-2028) & (US$/Unit)
Figure 16. Global Progesterone Receptor Agonist Production Capacity (2017-2028) & (K Units)
Figure 17. Global Progesterone Receptor Agonist Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Progesterone Receptor Agonist Market Drivers
Figure 19. Progesterone Receptor Agonist Market Restraints
Figure 20. Progesterone Receptor Agonist Market Trends
Figure 21. Global Progesterone Receptor Agonist Sales Market Share by Manufacturer in 2021
Figure 22. Global Progesterone Receptor Agonist Revenue Market Share by Manufacturer in 2021
Figure 23. Progesterone Receptor Agonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Progesterone Receptor Agonist Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Progesterone Receptor Agonist Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Progesterone Receptor Agonist Sales Market Share by Region (2017-2028)
Figure 27. Global Progesterone Receptor Agonist Revenue Market Share by Region (2017-2028)
Figure 28. North America Progesterone Receptor Agonist Revenue (2017-2028) & (USD Million)
Figure 29. Europe Progesterone Receptor Agonist Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Progesterone Receptor Agonist Revenue (2017-2028) & (USD Million)
Figure 31. South America Progesterone Receptor Agonist Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Progesterone Receptor Agonist Revenue (2017-2028) & (USD Million)
Figure 33. Global Progesterone Receptor Agonist Sales Market Share by Type (2017-2028)
Figure 34. Global Progesterone Receptor Agonist Revenue Market Share by Type (2017-2028)
Figure 35. Global Progesterone Receptor Agonist Price by Type (2017-2028) & (US$/Unit)
Figure 36. Global Progesterone Receptor Agonist Sales Market Share by Application (2017-2028)
Figure 37. Global Progesterone Receptor Agonist Revenue Market Share by Application (2017-2028)
Figure 38. Global Progesterone Receptor Agonist Price by Application (2017-2028) & (US$/Unit)
Figure 39. North America Progesterone Receptor Agonist Sales Market Share by Type (2017-2028)
Figure 40. North America Progesterone Receptor Agonist Sales Market Share by Application (2017-2028)
Figure 41. North America Progesterone Receptor Agonist Sales Market Share by Country (2017-2028)
Figure 42. North America Progesterone Receptor Agonist Revenue Market Share by Country (2017-2028)
Figure 43. United States Progesterone Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Progesterone Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Progesterone Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Progesterone Receptor Agonist Sales Market Share by Type (2017-2028)
Figure 47. Europe Progesterone Receptor Agonist Sales Market Share by Application (2017-2028)
Figure 48. Europe Progesterone Receptor Agonist Sales Market Share by Country (2017-2028)
Figure 49. Europe Progesterone Receptor Agonist Revenue Market Share by Country (2017-2028)
Figure 50. Germany Progesterone Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Progesterone Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Progesterone Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Progesterone Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Progesterone Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Progesterone Receptor Agonist Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Progesterone Receptor Agonist Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Progesterone Receptor Agonist Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Progesterone Receptor Agonist Revenue Market Share by Region (2017-2028)
Figure 59. China Progesterone Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Progesterone Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Progesterone Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Progesterone Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Progesterone Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Progesterone Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Progesterone Receptor Agonist Sales Market Share by Type (2017-2028)
Figure 66. South America Progesterone Receptor Agonist Sales Market Share by Application (2017-2028)
Figure 67. South America Progesterone Receptor Agonist Sales Market Share by Country (2017-2028)
Figure 68. South America Progesterone Receptor Agonist Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Progesterone Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Progesterone Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Progesterone Receptor Agonist Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Progesterone Receptor Agonist Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Progesterone Receptor Agonist Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Progesterone Receptor Agonist Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Progesterone Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Progesterone Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Progesterone Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Progesterone Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Progesterone Receptor Agonist in 2021
Figure 80. Manufacturing Process Analysis of Progesterone Receptor Agonist
Figure 81. Progesterone Receptor Agonist Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のトロンボポエチン受容体アゴニスト市場2022年：市場規模予測（～2028年）
  • 世界のグルカゴン様ペプチド-2（GLP-2）アゴニスト市場2022年：市場規模予測（～2028年）
  • 世界のアデノシン受容体A3市場2022年：市場規模予測（～2028年）
  • 世界の代謝型グルタミン酸受容体1型（mGluR1）市場2022年：市場規模予測（～2028年）
  • 世界の選択的グルココルチコイド受容体モジュレーター市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19571 )"世界のプロゲステロン受容体アゴニスト市場2022年：市場規模予測（～2028年）" (英文：Global Progesterone Receptor Agonist Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。